33 results on '"Bartkowiak, Todd"'
Search Results
2. Supplementary Figures from Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
3. Supplementary Table 1 from Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
4. Supplementary Figures from Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
5. Data from Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
6. Supplementary Table 1 from Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
7. Figure S7 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
8. Figure S5 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
9. Figure S1 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
10. Figure S2 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
11. Figure S2 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
12. Figure S7 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
13. Figure S4 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
14. Figure S4 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
15. Figure S6 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
16. Figure S6 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
17. Data from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
18. Figure S1 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
19. Supplemental Contents and Legends from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
20. Figure S3 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
21. Figure S5 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
22. Figure S3 from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
23. Supplemental Contents and Legends from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
24. Data from Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
25. Supplemental Figures and Legends from Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27–Dependent Pathway
26. Supplemental Figures and Legends from Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27–Dependent Pathway
27. Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
28. Abstract PR02: Melanoma evolves complete immunotherapy resistance through acquisition of a hypermetabolic phenotype
29. Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma
30. Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27–Dependent Pathway
31. Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
32. Abstract 629: Combination hypoxia-specific chemotherapy and immunotherapy of prostate cancer
33. Abstract 4290: Visualizing immune surveillance in lung metastasis progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.